Sunday, May 14, 2017 1:14:07 PM
May 01, 2017
SniffPhone: Detecting deadly diseases on the breath
Speaking of disease detection, two years ago, Prof. Hossam Haick of the Technion-Israel Institute of Technology introduced a device that can sense disease on the breath, much like a breathalyzer test. What Haick calls the SniffPhone uses nanotechnology sensors to analyze the particles on the breath and is able to pinpoint exact diseases, including certain kinds of cancer.
The SniffPhone, Haick’s new mobile device, contains his previously-developed ‘NaNose’ breathalyzer test, which “sniffs out” lung cancer before it spreads. The smartphone device is a vehicle for the NaNose technology that’s mobile and thus can be taken anywhere, including rural areas.
nocamels.com/2017/05/israeli-startups-inspire-better-world/
...Encore
Funding
This work was supported by the Southeast Center for Integrated
Metabolomics (SECIM) – National Institute of Health (NIH) [grant
number U24 DK097209]; and funding from Breathtec Biomedical,
Cannabix Technologies, and Agilent Technologies.
www.owlstonemedical.com/media/uploads/files/Portable-FAIMS-Applications-perspectives-Costanzo-2016.pdf
The Cannabix/Breathtec sisters have government support for their Research/Technology and Multi-Billion Dollar Agilent Technologies just bought a front row seat to MAR$.
I SEE BIG THINGS ON THE HORIZON
/////AMG
Recent AGNPF News
- Grey Matters Announces Private Placement • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation • GlobeNewswire Inc. • 04/15/2026 08:01:00 PM
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation • GlobeNewswire Inc. • 03/31/2026 11:09:55 PM
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers • GlobeNewswire Inc. • 03/25/2026 11:00:00 AM
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing • GlobeNewswire Inc. • 12/31/2025 09:01:00 PM
- Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche • GlobeNewswire Inc. • 12/23/2025 09:01:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/09/2025 05:01:20 PM
- Algernon Closes Second Tranche of Private Placement Financing • GlobeNewswire Inc. • 11/29/2025 12:51:39 AM
- Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement • GlobeNewswire Inc. • 11/17/2025 12:00:00 PM
- Algernon Closes First Tranche of its Recently Announced Private Placement Financing • GlobeNewswire Inc. • 11/15/2025 12:55:26 AM
- Algernon Health Announces Private Placement • GlobeNewswire Inc. • 11/06/2025 12:04:28 PM
- Algernon Pharmaceuticals Completes Name Change to Algernon Health • GlobeNewswire Inc. • 10/15/2025 11:00:00 AM
- Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection • GlobeNewswire Inc. • 09/25/2025 11:00:00 AM
- Algernon Announces Preferred Share Class Approved at Annual and Special Meeting • GlobeNewswire Inc. • 09/19/2025 08:39:57 PM
